NXGL · Nexgel, Inc.
$0.29
+0.00 (+0.34%)
At close · Sep 11
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an unrestricted cash balance of $0.5 million. For the six months ended June 30, 2026, the Company incurred a net loss of $4.5 million and had a net usage of cash in operating activities of $2,701 thousand. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 17, 2026
Market Cap
$2.84M
Shares
9.75M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.29
Open$0.29
Day$0.28–0.30
52W close$0.29–2.78
Avg vol 30d1.3M
Short int396K · 4.1% float · 1.0d
Short vol41%
Last earningsNov 12, 2025
DataDec 2021–Sep 2026
Filing10-Q · Aug 17
Up next
filed Aug 17, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$12.07M
Trailing 12 months
Net income (TTM)
−$6.22M
Trailing 12 months
Revenue growth YoY
+27.8%
Year over year
Operating margin
-44.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+17.8%
Year over year · more shares
Price change (1Y)
-88.2%
Trailing year
Short interest
4.1%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−67%
below
Price vs 50-day avg
−29%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−40%
trailing
6-month return
−58%
trailing
YTD return
−82%
this year
Relative strength
−75%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+9% holders QoQ · +7 funds added
Insider flow
Distributing
Net -$6.5K over 90 days · 100% sells
Short interest
Rising
4.06% of float · ▲ +47.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
24 holders — mid 3-yr range
Squeeze score
42
elevated · 0–100
Fundamentals
Revenue growth
+31%
Y/Y
Gross margin
39%
expanding
EPS growth
+24%
Y/Y
Free cash flow
$-1.4M
Quant / Vol
risk profile
Volatility
109%
annualized · 1-yr
Max drawdown
−90%
past year
ATR
14.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Dec 31, 2025
2026
EBITDA
$4M – $4.5M
upon closing
Pro forma annual revenue
Non-GAAP
$35M
Prior guidance
period ended
· from the 8-K filed Aug 14, 2024
Revenue
· third quarter of 2024
$2.2M
Revenue
· fourth quarter of 2024
$2.6M
Guided vs delivered
· last 2 settled
Revenue
third quarter of 2024
guided $2.2M
$2.94M
Beat +33.6%
Revenue
fourth quarter of 2024
guided $2.6M
$3.04M
Beat +17.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−67%
Bearish
Price vs 50-day avg
−29%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+9% holders QoQ · +7 funds added
Insider flow
Distributing
Net -$6.5K over 90 days · 100% sells
Short interest
Rising
4.06% of float · ▲ +47.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
24 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $3
vs 200-day avg -67%
vs 50-day avg -29%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NXGL
this stock
Nexgel, Inc.
|
$2.84M | -81.9% | +31.5% | — | 4.1% |
|
ISRG
Intuitive Surgical Inc
|
$130.41B | -34.8% | +20.5% | 42.4 | 2.2% |
|
BDX
Becton Dickinson & Co
|
$48.44B | — | +8.2% | — | 3.9% |
|
MDLN
Medline Inc.
|
$42.77B | -22.5% | +11.5% | — | 3.0% |
|
ALC
Alcon Inc
|
$31.92B | -16.2% | +10.5% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NXGL | -14.2% | -40.5% | -57.5% | -18.9% | -81.9% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -13.1% | -38.7% | -75.3% | -18.5% | -94.0% |